Is Alexion's Boston Move A Smoke Screen? – Hartford Courant
Drug maker Alexion to close R.I. plant
AstraZeneca's Alexion, Arvinas nab space at future 10-story biotech tower in New Haven | Fierce Biotech
Freshfields and Wachtell Guide AstraZeneca-Alexion Merger
AstraZeneca's Alexion hopes to extend dominance in PNH
Alexion Pharmaceuticals Will Move Headquarters To Boston | Connecticut Public
Alexion Pharmaceuticals Inc. plans to fire 20% of its global workforce as part of a restructuring effort
Alexion Pharmaceuticals, Inc. 2017 Q3 - Results - Earnings Call Slides (NASDAQ:ALXN) | Seeking Alpha
Alexion to Acquire Wilson Therapeutics | Business Wire
Alexion Pharmaceuticals loses general counsel, government affairs head amid Boston headquarters relocation - Boston Business Journal
Alexion Restructuring, Moving Headquarters to Boston – ISPE Boston
AstraZeneca earmarks $68.7M for two Alexion plants in Ireland
Alexion Pharmaceuticals Plans More Job Cuts - Drug Discovery and Development
Alexion Exits New Haven For Boston, Agrees To Repay Millions In State Aid – Hartford Courant
Alexion records $165M restructuring charge in 3Q; revenues up | Hartford Business Journal
AstraZeneca swung to 4Q loss despite revenue rise; expects $2.1 bln restructuring charge | Mint
JPM: Alexion gives an updated look at what AstraZeneca's getting for $39B | Fierce Pharma
Alexion scraps R&D programs, lays off staff after setbacks | Fierce Biotech
Activist Investor Urges Alexion to Sell Itself or Else | BioSpace
Restructuring Strategies // Alexion Partners | Global Management Advisory Firm
AlexionPartners | Global Management Consulting Firm
Alexion inks deal to acquire Achillion for $930M upfront | Fierce Biotech
Alexion to Restructure Operations, to Lower Headcount by 20%
Alexion to Restructure Operations, to Lower Headcount by 20%
Alexion Pharmaceuticals (ALXN) Slashes 20% of Its Workforce So It Could Boost Profits - TheStreet
New Haven's Alexion Cutting More Than 200 Jobs | Connecticut Public
